A unit of China’s Fosun Group has agreed to acquire 74% of Indian drug company Gland Pharma Ltd. for $1.1 billion, resurrecting a deal that was previously blocked by the Indian government.
from WSJ.com: US Business http://ift.tt/2wzfcZ9
via IFTTT
Good information. Thanks for sharing.
ReplyDeleteGland Pharma
Spandana Sphoorty IPO
Sterling & Wilson Solar IPO
Spandana Sphoorty Financial Ltd